This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Klyushnenkova, E. N. Articles by Alexander, R. B. Search for Related Content PubMed PubMed Citation Articles by Klyushnenkova, E. N. Articles by Alexander, R. B.

Identification of HLA-DRB1*1501–Restricted T-cell Epitopes from Prostate-Specific Antigen

Authors' Affiliations: ¹ Urology Section, VA Maryland Health Care System, and ² Division of Urology, University of Maryland School of Medicine, Baltimore, Maryland; ³ Department of Neuroimmunology, Portland VA Medical Center, and Departments of ⁴ Neurology and ⁵ Molecular Microbiology and Immunology, Oregon Health and Science University, Portland, Oregon

Requests for reprints: Elena N. Klyushnenkova, Department of Surgery, University of Maryland School of Medicine, 10 South Pine Street, Medical School Teaching Facility, Room 4-00A, Baltimore, MD 21201. Phone: 410-706-0755; Fax: 410-706-0311; E-mail: eklyushnenkova{at}smail.umaryland.edu.

The development of immunotherapy for prostate cancer based on the induction of autoimmunity to prostate tissue is very attractive because prostate is not a vital organ beyond the reproductive years. CD4 T cells play an important role in the development of antitumor immune responses, yet the identification of naturally processed MHC Class II–restricted epitopes derived from prostate differentiation antigens has not been described. To facilitate the search for prostate-specific antigen (PSA)–derived MHC class II–restricted peptides, we immunized mice transgenic for HLA-DRB1*1501 with human PSA and showed a robust dose-dependent immune response to the antigen. Screening a library of overlapping 20-mer peptides that span the entire PSA sequence identified two 20-mer peptides, PSA_171-190 and PSA_221-240, which were responsible for this reactivity. Immunization of DR2b transgenic mice with these peptides induced specific responses to the peptide and whole PSA. Identified peptides were used to stimulate CD4 T cells from HLA-DRB1*1501+ patients with a rare condition, granulomatous prostatitis, and who seem to have a preexisting immune response directed against the prostate gland. We previously showed a linkage of granulomatous prostatitis to HLA-DRB1*1501, suggesting that this disease may have an autoimmune etiology. Peptide-specific CD4 T-cell lines were generated from the peripheral blood of these patients as well as one patient with prostate cancer. These lines also recognized whole, processed PSA in the context of HLA-DRB1*1501. This study will be instrumental in understanding the interaction between circulating self-reactive T cells, organ-specific autoimmunity, and antitumor immune response. The use of these peptides for the immunotherapy of prostate cancer is under investigation.

Key Words: Granulomatous prostatitis • CD4 T lymphocytes • DR2b transgenic mice • HLA-DRB1*1501 • prostate cancer

This article has been cited by other articles:

				G. Penna, S. Amuchastegui, C. Cossetti, F. Aquilano, R. Mariani, N. Giarratana, E. De Carli, B. Fibbi, and L. Adorini Spontaneous and Prostatic Steroid Binding Protein Peptide-Induced Autoimmune Prostatitis in the Nonobese Diabetic Mouse J. Immunol., August 1, 2007; 179(3): 1559 - 1567. [Abstract] [Full Text] [PDF]